Literature DB >> 11389049

Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis.

X C Xu1, W Y Wong, L Goldberg, S C Baer, J E Wolf, W M Ramsdell, D S Alberts, S M Lippman, R Lotan.   

Abstract

Retinoids are essential for normal skin growth, differentiation, and apoptosis and are active pharmacologically in the prevention and treatment of skin cancers and other lesions. Retinoid effects are mediated mainly by retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which act as transcription factors to alter gene expression. Using in situ hybridization, we analyzed the expression of RARs and RXRs in normal sun-exposed skin (n = 85), squamous cell carcinoma (SCC; n = 28), and actinic keratosis [AK (a precursor to SCC); n = 38]. The expressions of five receptors (RAR-alpha and -gamma and RXR-alpha, -beta, and -gamma) were moderate to very strong in normal skin, with higher expressions in spinous and granular layers than in the basal layer. RAR-beta expression was weak or absent in normal and lesion samples. All five receptors expressed in the skin were suppressed progressively from normal skin to premalignant skin (AK) to invasive skin SCC. Specific receptor decreases in lesions relative to normal skin ranged from 75% (RXR-beta) to 96% (RAR-alpha) in SCC and from 37% (RAR-gamma) to 68% (RXR-beta) in AK. The degree of suppression of RXR-alpha and RAR-gamma, the two predominant retinoid receptors in skin, was relatively less for RXR-alpha (58% versus 86%; P = 0.015) and relatively greater for RAR-gamma (37% versus 89%; P = 0.0001) between AK and SCC, suggesting that suppression of RXR-alpha may be an earlier event and expression of RAR-gamma may be a later event of multistep squamous skin carcinogenesis. Our results indicate that suppressed expression of retinoid receptors occurs early (in AK) and is associated with progression of squamous skin carcinogenesis to SCC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389049

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Decreased Expression of Retinoid X Receptors During Human and Azoxymethane-induced Colorectal Carcinogenesis in the Rat.

Authors:  Xingpei Hao; Hang Xiao; Jihyueng Ju; Stephen M Hewitt; Herbert C Morse
Journal:  Anticancer Res       Date:  2016-06       Impact factor: 2.480

2.  All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.

Authors:  Noweeda Mirza; Mayer Fishman; Ingo Fricke; Mary Dunn; Anthony M Neuger; Timothy J Frost; Richard M Lush; Scott Antonia; Dmitry I Gabrilovich
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

3.  Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes.

Authors:  Yang-Yi Fan; Thomas E Spencer; Naisyin Wang; Mary P Moyer; Robert S Chapkin
Journal:  Carcinogenesis       Date:  2003-07-04       Impact factor: 4.944

4.  Signalling with retinoids in the human lung: validation of new tools for the expression study of retinoid receptors.

Authors:  Stéphane Poulain; Stéphanie Lacomme; Shyue-Fang Battaglia-Hsu; Stanislas du Manoir; Lydia Brochin; Jean-Michel Vignaud; Nadine Martinet
Journal:  BMC Cancer       Date:  2009-12-04       Impact factor: 4.430

5.  Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis.

Authors:  Po-Lin So; Michele A Fujimoto; Ervin H Epstein
Journal:  Mol Cancer Ther       Date:  2008-05       Impact factor: 6.261

Review 6.  Nuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesis.

Authors:  Stephen Hyter; Arup K Indra
Journal:  FEBS Lett       Date:  2013-02-05       Impact factor: 4.124

7.  Glottic versus supraglottic tumors: differential molecular profile.

Authors:  Konstantinos Kourelis; Theodoros Papadas; Gerasimos Vandoros; Panos Goumas; Georgia Sotiropoulou-Bonikou
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-02       Impact factor: 2.503

8.  Activation of the CRABPII/RAR pathway by curcumin induces retinoic acid mediated apoptosis in retinoic acid resistant breast cancer cells.

Authors:  Padmamalini Thulasiraman; Galen Garriga; Veena Danthuluri; Daniel J McAndrews; Imran Q Mohiuddin
Journal:  Oncol Rep       Date:  2017-03-08       Impact factor: 3.906

9.  The proteosome inhibitor MG132 attenuates retinoic acid receptor trans-activation and enhances trans-repression of nuclear factor kappaB. Potential relevance to chemo-preventive interventions with retinoids.

Authors:  Valentine B Andela; Randy N Rosier
Journal:  Mol Cancer       Date:  2004-03-22       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.